杏贝止咳颗粒辅助西药治疗外寒内热证咳嗽变异性哮喘临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R256.12

基金项目:


Clinical Study on Xingbei Zhike Granules and Western Medicine for Cough Variant Asthma with Syndrome of External Cold and Internal Heat
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察杏贝止咳颗粒辅助西药治疗外寒内热证咳嗽变异性哮喘(CVA) 的临床疗效。方法: 选取206例CVA患者作为研究对象,按简单随机化法分为治疗组与对照组各103例,最终治疗组101例(剔除 2例)、对照组100例(剔除2例) 完成试验。对照组给予常规西药对症治疗,治疗组给予杏贝止咳颗粒辅助西 药对症治疗。2组均连续治疗14 d,评估2组临床疗效、中医证候评分、莱切斯特咳嗽问卷(LCQ) 评分、肺 功能[最大呼吸流速(PEF)、用力肺活量(FVC)、第1秒用力呼气容积(FEV1)] 及血清炎症因子[白细胞 介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)] 水平。结果:治疗组总有效率为93.07%,对照组为82.00%, 2组比较,差异有统计学意义(P<0.05)。治疗后,2组中医证候评分均较治疗前降低(P<0.05),且治疗组中 医证候评分低于对照组(P<0.05)。治疗后,2组心理区域、生理区域、社会区域等LCQ评分及总分均较治疗 前升高(P<0.05),且治疗组LCQ各项评分及总分均高于对照组(P<0.05)。治疗后,2组PEF、FVC、FEV1 水平均较治疗前升高(P<0.05),且治疗组上述3项指标均高于对照组(P<0.05)。治疗后,2组血清IL-6、 TNF-α水平均较治疗前降低(P<0.05),且治疗组上述2项指标均低于对照组(P<0.05)。结论:杏贝止咳颗 粒辅助西药对症治疗外寒内热证CVA疗效确切,可减轻患者临床症状,改善肺功能,抑制体内炎症反应,减 轻咳嗽对患者生活质量的影响。

    Abstract:

    Abstract:Objective:To observe the clinical effect of Xingbei Zhike Granules and western medicine on cough variant asthma (CVA) with syndrome of external cold and internal heat. Methods:A total of 206 CVA patients were selected as study objects and divided into the treatment group and the control group according to the simple randomization method, with 103 cases in each group. Finally, 101 cases in the treatment group (excluding two cases) completed the trial; 100 cases in the control group (excluding two cases) completed the trial. The control group was treated with conventional symptomatic western medicine, and the treatment group was given Xingbei Zhike Granules and western medicine. After 14 days of treatment, the clinical effects, traditional Chinese medicine (TCM) syndrome scores, Leicester Cough Questionnaire (LCQ), lung function [peak expiratory flow (PEF), forced vital capacity (FVC), forced expiratory volume in one second (FEV1)] and levels of serum inflammatory factors [interleukin-6 (IL-6), tumor necrosis factor- α (TNF-α)] in the two groups were evaluated. Results:The total effective rate was 93.07% in the treatment group and 82.00% in the control group,the difference being significant (P<0.05). After treatment,the TCM syndrome scores in the two groups were decreased when compared with those before treatment (P<0.05),and the TCM syndrome scores in the treatment group were lower than those in the control group (P<0.05). After treatment, the scores of psychological area, physiological area, social area and total scores of LCQ in the two groups were increased when compared with those before treatment (P<0.05),and the LCQ sub-scores above and the total score of LCQ in the treatment group were higher than those in the control group (P<0.05). After treatment, the levels of PEF, FVC and FEV1 in the two groups were increased when compared with those before treatment (P<0.05),and the above three levels in the treatment group were higher than those in the control group (P<0.05). After treatment,the levels of serum IL-6 and TNF-α in the two groups were decreased when compared with those before treatment (P< 0.05), and the above two levels in the treatment group were lower than those in the control group (P< 0.05). Conclusion:The therapy of Xingbei Zhike Granules and western medicine has a definite therapeutic effect on the symptomatic treatment of CVA with syndrome of external cold and internal heat,which can relieve the clinical symptoms,improve lung function,inhibit the inflammatory responses of the body,and reduce the impact of cough on the quality of life of patients.

    参考文献
    相似文献
    引证文献
引用本文

刘晨.杏贝止咳颗粒辅助西药治疗外寒内热证咳嗽变异性哮喘临床研究[J].新中医,2024,56(14):80-84

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2024-07-28
  • 出版日期:
文章二维码